BIPAVE-001 is a Phase 1-2 study for evaluating the safety, pharmacokinetics (PK), and efficacy of AI-081 in solid tumors.
- Investigator
- Thomas J George
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
BIPAVE-001 is a Phase 1-2 study for evaluating the safety, pharmacokinetics (PK), and efficacy of AI-081 in solid tumors.
This phase II ADC MATCH screening and multi-sub-study treatment trial is evaluating whether biomarker-directed treatment with one of three antibody-drug conjugates (ADCs) (sacituzumab govitecan, enfortumab vedotin, and trastuzumab deruxtecan) works…
March 24, 2026
GAINESVILLE, Fla. — Type 1 diabetes researchers have made great progress in understanding the disease in the last two decades, even as a cure remains elusive.…
Department of Pathology, Immunology, and Laboratory Medicine, +4 more
March 12, 2026
JUPITER, Fla. — The newest faculty member to join The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jinyoung Kang, Ph.D., is…
The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
A fluffy, long-necked cousin of the camel might be the key to protecting against SARS-like viruses. Yes, you heard that correctly. In a new study from researchers in Belgium, a team discovered a...
Your next blood glucose meter reading could be a lot more revealing. In addition to confirming blood sugar levels, it might also determine the level of antibodies that protect against...